Some 56 countries fell short of the WHO's goal of getting 10% of their populations immunized against the virus by the end of September.
More than two dozen countries in Africa have fully immunized 2% or less of their populations, while two African nations have yet to receive any vaccines.
Some 56 countries fell short of the WHO's goal of getting 10% of their populations immunized against the virus by the end of September, officials said in a Q&A live streamed on the organization's social media channels. Increasing access to vaccines would help reduce Covid deaths and hospitalizations as the world approaches 5 million coronavirus fatalities, said Maria Van Kerkhove, the WHO's technical lead for Covid-19.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Former football player's mission to get others vaccinated after almost dying of COVID36-year-old Justin Moon spent nearly 6 weeks on a ventilator.
Leer más »
Pfizer Tests Pill That Could Prevent Covid InfectionI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Leer más »
Merck says experimental pill cuts worst effects of CovidMerck says its experimental Covid-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.
Leer más »
Fauci says new pill 'impressive' at keeping COVID patients alive and out of hospitalsA new pill to treat COVID-19 has shown “impressive” results in clinical trials, Dr. Anthony Fauci said during a Friday briefing of the White House pandemic response team. The drug, molnupiravir, is an antiviral treatment developed by Merck in conjunction with Ridgeback Biotherapeutics.
Leer más »
Fauci notes COVID-19 progress but warns more surges are possibleAs the U.S. sees its first notable decline in COVID-19 metrics in more than three months, with coronavirus-related hospital admissions and average daily new cases dropping by more than 30% over the last month, Dr. Anthony Fauci says the country is making progress against the current surge, but warned we're not out of the woods yet during an interview on ABC's 'This Week.' 'We certainly are turning the corner on this particular surge, Jon,' the nation's top infectious disease expert told 'This Week' co-anchor Jonathan Karl on Sunday. 'So it's within our capability to make sure that that turnaround that we’re seeing -- that very favorable and optimistic turnaround -- continues to go down and doesn't do what we've seen multiple times before, where it goes down and then it comes back up.'
Leer más »
Japan stocks set to rise after Merck announces new Covid treatment; China markets closedMerck and Ridgeback Biotherapeutics announced Friday they’ve developed a drug which reduces the risk of hospitalization or death by around 50% in Covid patients.
Leer más »